Prevalence and prognostic significance of COX-2 expression in stage IB cervical cancer

Gynecologic Oncology

Volumn 100, Issue 3, 2006, Pages 556-560

  Manchana, Tarinee ^a   Triratanachat, Surang ^a   Sirisabya, Nakarin ^a   Vasuratna, Apichai ^a   Termrungruanglert, Wichai ^a   Tresukosol, Damrong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

COX 2 expression; Immunohistochemistry; Prognostic factor; Stage IB cervical cancer

Indexed keywords

CYCLOOXYGENASE 2;

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MEDICAL RECORD; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; UTERINE CERVICAL NEOPLASMS;

EID: 32644488718     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.09.014     Document Type: Article

References (33)

1. Deerasamee S, Martin N, Sontipong S, Sriamporn S, Sriplung H, Srivatanakul P, et al. Cancer in Thailand 1992-1994, IARC Technical Report no. 34. Lyon: IARC; 1999, p. 56-9.
2. H.M. Shingleton, and J.W. Orr Jr. Cancer of the cervix 1995 J.B. Lippincott Philadelphia 37 154
3. N. Takeda, N. Sakuragi, M. Takeda, K. Okamoto, M. Kuwabara, and H. Negishi Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy Acta Obstet. Gynecol. Scand. 81 2002 1144 1151
4. Y. Aoki, M. Watanabe, M. Sasaki, T. Sato, H. Kase, and H. Aida Prognostic factors and failure pattern in lymph node-negative stage IB and II cervical carcinoma treated with radical hysterectomy and postoperative irradiation Gynecol. Obstet. Invest. 52 2001 13 17
5. C.S. Williams, and R.N. DuBois Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol. 270 1996 393 400
6. W.L. Smith, R.M. Garavito, and D.L. DeWitt Prostaglandin endoperoxidase H synthases (cyclooxygenases)-1 and -2 J. Biol. Chem. 271 1996 33157 33160
7. J.L. Masferrer, K.M. Leahy, A.T. Koki, B.S. Zweifel, S.L. Settle, and B.M. Woerner Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors Cancer Res. 60 2000 1306 1311
8. M. Tsujii, and R.N. DuBois Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 Cell 83 1995 493 501
9. C.E. Eberhart, F.J. Coffey, A. Radhika, F.M. Giardiello, S. Ferrenbach, and R.N. DuBois Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1994 1183 1188
10. A. Ristimaki, A. Sivula, J. Lundin, M. Lundin, T. Salminen, and C. Haglund Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer Cancer Res. 62 2002 632 635
11. S. Hasturk, B. Kemp, S.K. Kalapurakal, J.M. Kurie, W.K. Hong, and J.S. Lee Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma Cancer 94 2002 1023 1031
12. A. Ristimaki, N. Honkanen, H. Jankala, P. Sipponen, and M. Harkonen Expression of cyclooxygenase-2 in human gastric carcinoma Cancer Res. 57 1997 1276 1280
13. G. Ferrandina, F.O. Ranelletti, L. Lauriola, F. Fanfani, F. Legge, and M. Mottolese Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer Gynecol. Oncol. 85 2002 305 310
14. C. Denkert, M. Kobel, S. Pest, I. Koch, S. Berger, and M. Schwabe Expression of cyclooxygenase-2 is and independent prognostic factor in human ovarian carcinoma Am. J. Pathol. 160 2002 893 903
15. G. Ferrandina, F. Legge, F.O. Ranelletti, G.F. Zannoni, N. Maggiano, and A. Evangelisti Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome Cancer 95 2002 801 807
16. S. Kulkarni, J.S. Rader, F. Zhang, H. Liapis, A.T. Koki, and J.L. Masferrer Cyclooxygenase-2 is overexpressed in human cervical cancer Clin. Cancer Res. 7 2001 429 434
17. N. Nagai, X. Tian, K. Mukai, E. Hirata, T. Kusuda, and Y. Shiroyama Overexpression of cyclooxygenase-2 protein and its relationship to apoptosis in cervical carcinoma treated with neoadjuvant chemotherapy Int. J. Mol. Med. 12 2003 709 714
18. M.H. Kim, S.S. Seo, Y.S. Song, D.H. Kang, I.A. Park, and S.B. Kang Expression of cyclooxygenase-1 and 2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes Gynecol. Oncol. 90 2003 83 90
19. D.K. Gaffney, J. Holden, M. Davis, K. Zempolich, K.J. Murphy, and M. Dodson Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 49 2001 1213 1217
20. D.K. Gaffney, J. Holden, K. Zempolich, K.J. Murphy, A.P. Dicker, and M. Dodson Elevated COX-2 expression in cervical carcinoma: reduced cause-specific survival and pelvic control Am. J. Clin. Oncol. 24 2001 443 446
21. Y.B. Kim, G.E. Kim, N.H. Cho, H.R. Pyo, S.J. Shim, and S.K. Chang Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy Cancer 95 2002 531 539
22. G. Ferrandina, L. Lauriola, M.G. Distefano, G.F. Zannoni, M. Gessi, and F. Legge Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients J. Clin. Oncol. 20 2002 973 981
23. J. Farley, C. Uyehara, G. Hashiro, C. Belnap, M. Birrer, and E. Salminen Cyclooxygenase-2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure Gynecol. Oncol. 92 2004 596 602
24. H.S. Ryu, K.H. Chang, H.W. Yang, M.S. Kim, H.C. Kwon, and K.S. Oh High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion Gynecol. Oncol. 76 2000 320 325
25. H.J. Kim, H.G. Wu, I.A. Park, and S.W. Ha High cyclooxygenase-2 expression is related with distant metastasis in cervical cancer treated with radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 55 2003 16 20
26. Y.J. Chen, L.S. Wang, P.H. Wang, C.R. Lai, M.S. Yen, and H.T. Ng High cyclooxygenase-2 expression in cervical adenocarcinomas Gynecol. Oncol. 88 2003 379 385
27. Y.B. Kim, G.E. Kim, H.R. Pyo, N.H. Cho, K.C. Keum, and C.G. Lee Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix Int. J. Radiat. Oncol. Biol. Phys. 60 2004 822 829
28. F. Landoni, A. Maneo, A. Colombo, F. Placa, R. Milani, and P. Perego Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer Lancet 350 1997 535 540
29. M.A. Finan, S. DeCesare, J.V. Fiorica, R. Chambers, M.S. Hoffman, and R.C. Kline Radical hysterectomy for stage IB1 vs. IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival? Gynecol. Oncol. 62 1996 139 147
30. J.E. Sardi, A. Giaroli, C. Sananes, M. Ferreira, A. Soderini, and A. Bermudez Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results Gynecol. Oncol. 67 1997 61 69
31. W. Termrungruanglert, D. Tresukosol, A. Vasuratna, T. Sittisomwong, R. Lertkhachonsuk, and N. Sirisabya Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage IB2 Gynecol. Oncol. 97 2005 576 581
32. G. Ferrandina, F.O. Ranelletti, F. Legge, L. Lauriola, V. Salutari, and M. Gessi Celocoxib modulates the expression of cyclooxygenase-2, Ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study Clin. Cancer Res. 9 2003 4324 4331
33. J.S. Lee, Y.D. Choi, J.H. Lee, J.H. Nam, C. Choi, and M.C. Lee Expression of cyclooxygenase-2 in adenocarcinomas of the uterine cervix and its relation to angiogenesis and tumor growth Gynecol. Oncol. 95 2004 523 529